Ezetimibe Articles

Articles
The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study
Moon JS, Park IR, Kim SS, et al.
Journal:
Diabetes Metab J

First published: November 24, 2023 DOI: 10.4093/dmj.2023.0171
View
- Share
Articles
Bempedoic acid – how will it shape the future lipid-lowering landscape? Mode of action, evidence, and clinical use
Drexel H, Mader A
Journal:
Cardiology

First published: November 21, 2023 DOI: 10.1159/000535372
View
- Share
Articles
Moderate-intensity statin plus ezetimibe vs high-intensity statin according to baseline LDL-C in the treatment of atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING randomized trial
Lee B, Hong SJ, Rha SW, et al.
Journal:
Atherosclerosis

First published: November 10, 2023 DOI: 10.1016/j.atherosclerosis.2023.117373
View
- Share
Articles
Efficacy and Safety of Single-Pill Combination of Rosuvastatin and Ezetimibe in Chinese Patients with Primary Hypercholesterolemia Inadequately Controlled by Statin Treatment (ROZEL): A Randomized, Double-Blind, Double Dummy, Active-Controlled Phase 3 Clinical Trial
Su Q, Liu Y, Zhang G, et al.
Journal:
Adv Ther

First published: September 28, 2023 DOI: 10.1007/s12325-023-02666-z
View
- Share
Articles
Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial
Lee SJ, Cha JJ, Choi WG, et al.
Journal:
JAMA Cardiol

First published: August 2, 2023 DOI: 10.1001/jamacardio.2023.2222
View
- Share
Articles
Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT
Shah NP, McGuire DK, Cannon CP, et al.
Journal:
J Am Heart Assoc

First published: June 22, 2023 DOI: 10.1161/JAHA.122.029593
View
- Share
Articles
Simulation of bempedoic acid and ezetimibe in the lipid-lowering treatment pathway in Austria using the contemporary SANTORINI cohort of high and very high risk patients
Toplak H, Bilitou A, Alber H, et al.
Journal:
Wien Klin Wochenschr

First published: June 8, 2023 DOI: 10.1007/s00508-023-02221-4
View
- Share
Articles
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial
Ballantyne CM, Ditmarsch M, Kastelein JJ, et al.
Journal:
J Clin Lipidol

First published: May 31, 2023 DOI: 10.1016/j.jacl.2023.05.098
View
- Share
Articles
Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis
Lee SH, Lee YJ, Heo JH, et al.
Journal:
J Am Coll Cardiol

First published: April 3, 2023 DOI: 10.1016/j.jacc.2023.02.007
View
- Share
Articles
Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial
Lee YJ, Cho JY, You SC, et al.
Journal:
Eur Heart J

First published: December 19, 2022 DOI: 10.1093/eurheartj/ehac709
View
- Share
Articles
Inclisiran and cardiovascular events: a patient-level analysis of phase III trials
Ray KK, Raal FJ, Kallend DG, et al.
Journal:
Eur Heart J

First published: November 4, 2022 DOI: 10.1093/eurheartj/ehac594
View
- Share
Articles
Potential Cardiovascular Events Avoided with Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared with Ezetimibe Alone in Patients with Atherosclerotic Cardiovascular Disease Taking Maximally Tolerated Statins
McQueen RB, Baum SJ, Louie MJ, et al.
Journal:
Am J Cardiovasc Drugs

First published: October 31, 2022 DOI: 10.1007/s40256-022-00552-7
View
- Share

1 2

Ezetimibe Articles

Articles

The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study

Moon JS, Park IR, Kim SS, et al.

Articles

Bempedoic acid – how will it shape the future lipid-lowering landscape? Mode of action, evidence, and clinical use

Drexel H, Mader A

Articles

Moderate-intensity statin plus ezetimibe vs high-intensity statin according to baseline LDL-C in the treatment of atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING randomized trial

Lee B, Hong SJ, Rha SW, et al.

Articles

Efficacy and Safety of Single-Pill Combination of Rosuvastatin and Ezetimibe in Chinese Patients with Primary Hypercholesterolemia Inadequately Controlled by Statin Treatment (ROZEL): A Randomized, Double-Blind, Double Dummy, Active-Controlled Phase 3 Clinical Trial

Su Q, Liu Y, Zhang G, et al.

Articles

Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial

Lee SJ, Cha JJ, Choi WG, et al.

Articles

Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT

Shah NP, McGuire DK, Cannon CP, et al.

Articles

Simulation of bempedoic acid and ezetimibe in the lipid-lowering treatment pathway in Austria using the contemporary SANTORINI cohort of high and very high risk patients

Toplak H, Bilitou A, Alber H, et al.

Articles

Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial

Ballantyne CM, Ditmarsch M, Kastelein JJ, et al.

Articles

Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis

Lee SH, Lee YJ, Heo JH, et al.

Articles

Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial

Lee YJ, Cho JY, You SC, et al.

Articles

Inclisiran and cardiovascular events: a patient-level analysis of phase III trials

Ray KK, Raal FJ, Kallend DG, et al.

Articles

Potential Cardiovascular Events Avoided with Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared with Ezetimibe Alone in Patients with Atherosclerotic Cardiovascular Disease Taking Maximally Tolerated Statins

McQueen RB, Baum SJ, Louie MJ, et al.

Articles

The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study

Moon JS, Park IR, Kim SS, et al.

Share

Articles

Bempedoic acid – how will it shape the future lipid-lowering landscape? Mode of action, evidence, and clinical use

Drexel H, Mader A

Share

Articles

Moderate-intensity statin plus ezetimibe vs high-intensity statin according to baseline LDL-C in the treatment of atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING randomized trial

Lee B, Hong SJ, Rha SW, et al.

Share

Articles

Efficacy and Safety of Single-Pill Combination of Rosuvastatin and Ezetimibe in Chinese Patients with Primary Hypercholesterolemia Inadequately Controlled by Statin Treatment (ROZEL): A Randomized, Double-Blind, Double Dummy, Active-Controlled Phase 3 Clinical Trial

Su Q, Liu Y, Zhang G, et al.

Share

Articles

Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial

Lee SJ, Cha JJ, Choi WG, et al.

Share

Articles

Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT

Shah NP, McGuire DK, Cannon CP, et al.

Share

Articles

Simulation of bempedoic acid and ezetimibe in the lipid-lowering treatment pathway in Austria using the contemporary SANTORINI cohort of high and very high risk patients

Toplak H, Bilitou A, Alber H, et al.

Share

Articles

Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial

Ballantyne CM, Ditmarsch M, Kastelein JJ, et al.

Share

Articles

Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis

Lee SH, Lee YJ, Heo JH, et al.

Share

Articles

Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial

Lee YJ, Cho JY, You SC, et al.

Share

Articles

Inclisiran and cardiovascular events: a patient-level analysis of phase III trials

Ray KK, Raal FJ, Kallend DG, et al.

Share

Articles

Potential Cardiovascular Events Avoided with Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared with Ezetimibe Alone in Patients with Atherosclerotic Cardiovascular Disease Taking Maximally Tolerated Statins

McQueen RB, Baum SJ, Louie MJ, et al.

Share